Providence receives FDA clearance for Cavux cervical cage and Ally facet screws

Providence Medical Technology Cavux

Providence Medical Technology has announced recent 510(k) clearances from the US Food and Drug Administration for the standalone use of the Cavux cervical cage-L system as well as approval for its Ally facet screws. 

The Cavux cervical cage-L system is manufactured from medical grade titanium and available in a variety of sizes. The implant comprises proprietary grit-blasted and acid-etched surfaces, a large space for allogenic and autogenous bone graft and includes self-drilling and self-tapping screws intended to provide additional, standalone fixation.

The Ally facet screws are designed to provide temporary stabilisation as an adjunct to spinal fusion.  The titanium implants are available in a variety of sizes to accommodate patient anatomy and are intended to provide mechanical support and stability until spinal fusion is achieved.

Providence Medical Technology has also announced the addition of two industry veterans to the commercial leadership team.  Scott Lynch and Michael Scott have joined Providence Medical Technology in Global Marketing and International leadership positions, respectively.  Lynch and Scott have over 40 years of combined industry experience.

Lynch joins the company with over 22 years of medical device and 15 years of spine industry marketing experience, having previously served as vice president of Global Marketing at DFINE, VertiFlex, and Zimmer Spine.

Scott joins Providence following over 16 years at ArthroCare as vice president of OUS Sports Medicine, vice president of Asia Pacific Commercial Operations, and US vice president ENT Sales at Smith & Nephew.